Abstract
Aims: Rett syndrome is caused by mutations in the MECP2 gene. In 2012, it was reported in NATURE that bone marrow transplantation (BMT) in MECP2 null mice drastically increases lifespan and ameliorates the pathological phenotype. As BMT is associated with a significant mortality, it is important to reproduce these results before clinical trials in humans can be performed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
